Latest news
Loading news…
Actimis Pharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). San Diego, California, United States Founded 2004 11-50 employees For Profit
Actimis Pharmaceuticals is a biopharmaceutical company developing small molecule therapeutics for respiratory and inflammatory disorders.
Actimis Pharmaceuticals was acquired by Boehringer Ingelheim in 2008 for $515M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 1
- Active products
- 7
Company Info
- Founded
- 2004
- Employees
- 11-50
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 1
- HQ
- San Diego, California, United States
- Region
- Greater San Diego Area, West Coast, Western US
- Exit date
- Jun 17, 2008
- Closed
- Jan 1, 2008
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.2
- Trend (30d)
- 2.9
- Trend (90d)
- 0.5
Key People at Actimis Pharmaceuticals
Director
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Actimis Pharmaceuticals
Loading news…
FAQs about Actimis Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.